• Exclusive access to 500,000-1,000,000 echocardiography studies
• Partnership with Advara HeartCare strengthens AI product development
• Agreement provides initial three-year term with an option to extend

Echo IQ Limited, an AI and medical technology company, has executed a definitive exclusive data licensing agreement with Advara HeartCare, Australia's largest private cardiovascular diagnostics provider. This agreement provides Echo IQ with exclusive access to a substantial dataset of de-identified echocardiography studies and associated clinical information, sourced from Advara's national network. The dataset is expected to comprise between 500,000 and 1,000,000 de-identified echocardiographic studies, echocardiographic images, and associated clinical datasets. This strategic data asset is anticipated to significantly enhance future EchoSolv product development, training, and validation of next-generation cardiovascular AI products. The agreement is expected to support the expansion of Echo IQ's future product pipeline and strengthen its competitive position.